Tangle - Trump unveils his "Great Healthcare Plan."
Episode Date: January 21, 2026On Thursday, January 15, President Donald Trump announced several proposals to lower health insurance costs, which he called “The Great Healthcare Plan.” The healthcare-reform framework ...focuses on four broad initiatives: lowering drug prices, lowering insurance premiums, holding big insurance companies accountable, and maximizing price transparency. Although the White House has not announced specific legislative proposals to enact the policy, Trump specified he would seek to make more medications available over the counter, regulate pharmacy benefit managers (PBMs), and require insurance companies to explain their costs in simple and clear language.Ad-free podcasts are here!To listen to this podcast ad-free, and to enjoy our subscriber only premium content, go to ReadTangle.com to sign up!Want to get texts from Tangle?Since October, over 13,000 Tangle readers have joined us on Subtext, our free SMS messaging service that lets us connect directly with readers. Subtext subscribers can weigh in on our coverage through topic polls, receive analysis on developing stories straight from Isaac, and get occasional peeks behind the scenes at Tangle’s operations. You can sign up for Subtext here!(Note: Subtext is currently only available for subscribers based in the U.S. and Canada.)You can read today's podcast here, our “Under the Radar” story here and today’s “Have a nice day” story here.You can subscribe to Tangle by clicking here or drop something in our tip jar by clicking here. Take the survey: Which healthcare reforms would you support? Let us know.Our Executive Editor and Founder is Isaac Saul. Our Executive Producer is Jon Lall.This podcast was written by: Will Kaback and audio edited and mixed by Dewey Thomas. Music for the podcast was produced by Diet 75.Our newsletter is edited by Managing Editor Ari Weitzman, Senior Editor Will Kaback, Lindsey Knuth, Bailey Saul, and Audrey Moorehead. Hosted on Acast. See acast.com/privacy for more information.
Transcript
Discussion (0)
From executive producer Isaac Saul, this is Tangle.
Good morning, good afternoon, and good evening, and welcome to the Tangle podcast, a place where you get views from across the political spectrum, some independent thinking, and a little bit of our take.
I'm your host, Senior Editor, Will Kayback.
Today's main story is one that you could be forgiven for not having paid much attention to given, given everyone.
everything else that's been in the news for the past week. I mean, really, just in the past 24 hours,
we've had big news on Donald Trump's Board of Peace in Gaza in the second phase of that ceasefire deal,
the ongoing protests against ICE in Minnesota and the federal government's response,
the Greenland issue that we covered yesterday, and President Trump's subsequent remarks about it
today in Switzerland at the Davos conference. So there has been a ton going on. A lot of it focused on
world issues. But as I noted my take, it's a little funny that this story has fell off the radar,
given how big of an issue it was in the 2024 campaign and really throughout Trump's time in politics
over the past decade. And that is his much-awaited, much-anticipated health care plan,
which he released last week amid several other health care-related moves by Congress in the past few
days. So we're going to break down what exactly is in the plan and the proposal that Trump put forward
last week, what the legislative prospects for those proposals are, and what the scale of these
reforms could actually look like in practice. There's a lot to get into a little bit more of a policy
focus today, which hopefully feels like a nice change of pace. Before we dive in, though, I want to
flag a Tangle service that you might not know about, and that is Subtext. So since October,
over 13,000 members of the Tangle community have joined us on the Subtext platform, which is our
free SMS messaging service that lets us connect directly with you, our audience.
So if you're a subtext subscriber, you can weigh in on our coverage topics for the week
through polls that we send out. You'll receive up-to-date analysis on developing stories as
soon as they happen coming straight from Isaac. And you'll also get the occasional peek
behind the curtain at Tangle's operations. So if that sounds like something that's interesting
to you, you can sign up for our subtext. Again, it is free. And we'll put the link to it in our
for today. A quick note that this is only available for subscribers based in the U.S. and Canada right now,
but we're working to expand the offering to people in other countries. All right, I'm going to hand
it over to John for today's quick hits, our main topic, what the left and right are saying,
and then I'll be back to read my take. John, over to you.
Thanks, Isaac, and welcome, everybody. Here are your quick hits for today. First up, Congress
released a bipartisan government funding bill ahead of the January 30th deadline to avoid a shutdown,
Democrats in the House and Senate are expected to challenge provisions for the Department of Homeland Security,
seeking further reforms to immigration and customs enforcement's operations.
Number two, President Donald Trump will speak at the World Economic Forum on Wednesday
and is expected to address strained U.S.-Europe relations amid his push to acquire Greenland.
On Tuesday, Canadian Prime Minister Mark Carney addressed the gathering,
alluding to the Trump administration's actions as causing a rupture in the world order.
Number three, the Justice Department subpoenaed five Minnesota government.
government offices, including the governor's office, the Attorney General's office, and the Minneapolis
mayor's office, omitted its investigations into alleged efforts to obstruct federal immigration
operations in the state. Number four, Attorney General Pam Bondi announced that Lindsay Halligan
is leaving her rule as interim U.S. attorney for the Eastern District of Virginia.
Halligan had brought charges against former Federal Bureau of Investigation Director James Comey and New York
Attorney General Letitia James, but courts dismissed the cases after finding Halligan was
illegally appointed.
And number five, Australia's parliament passed a series of gun control laws in response to the mass shooting that killed 15 people at a Hanukkah celebration at Bondi Beach in Sydney in December.
The new laws create a national gun buyback program, limit imports of firearms, and enhance background checks.
The White House just releasing a new document on health care within the past few moments.
The White House laying out some goals and objectives here for health care legislation on Capitol Hill this year.
So some of these priorities will be familiar to people, particularly around drug pricing and insurance companies.
What the White House is saying in a conference call that's going on right now, Dr. Amendment
Oz, the administrator of CMS, calls this a framework for legislation to be passed later this year.
On Thursday, January 15th, President Donald Trump announced several proposals to lower health insurance costs, which he called the Great Healthcare Plan.
The health care reform framework focuses on four broad initiatives, lowering drug prices, lowering,
insurance premiums, holding big insurance companies accountable, and maximizing price transparency.
Although the White House has not announced specific legislative proposals to enact the policy,
Trump specified he would seek to make more medications available over the counter,
regulate pharmacy benefit managers, and require insurance companies to explain their costs
in simple and clear language. Separately on Tuesday, congressional leaders reached a bipartisan
deal in both chambers to advance a four-bill minibus spending package that includes several
health care stipulations. The spending bills set funding levels for the departments of
defense, transportation, labor, health and human services, and homeland security. The HHS bill
limits PBM benefits, extends telehealth coverage, and extends funding for at-home Medicare and
Medicaid services through 2030. The health care deal revives a 2024 bill scuttled by then-President
Trump and Elon Musk over spending concerns. The new spending bill pursues many of the same
goals as its predecessor. It also does not take up the Affordable Care Act subsidies,
which expired at the end of 2025 and were central to last year's prolonged government shutdown.
Democrats proposed extending the expanded benefits for three years in a bill that passed the House
on January 8th but has since stalled in the Senate.
We previously covered the government shutdown and the expiring ACA benefits.
There are links to both of those articles in today's episode description.
The path to enacting the proposals in the President's great health care plan is unclear,
and statements from Republicans indicate that changing the current bipartisan spending agreement
would be difficult.
You're going to need 218 votes, which means you're going to need to build consensus across the conference on what it is we're pursuing, Representative Mike Lawler said.
Senator Josh Hawley called the GOP's health care options pretty limited.
Democrats dismiss Trump's framework as ineffective.
Trump's great health care plan does nothing to substantively bring down health care costs, Democratic National Committee Rapid Response Director Kendall Whitmer said.
Today, we'll get into what the left and right are saying about the president's health care plan and Congress's spending bill.
And then, senior editor Will Kayback will give his take.
We'll be right back after this quick break.
All right. First up, let's start with what the left is saying.
Many on the left are critical of the health care plan, arguing that it has little substance.
Some argue that the plan doesn't lay out a clear legislative strategy.
Others say that Trump's proposals won't lower health care costs.
In public notice, Paul Waldman said Trump's long-awaited health care plan is a joke.
The plan does contain a few things that look like big ideas, but are our
immediately baffling, Waldman wrote. The biggest one is this. The government is going to pay the money
directly to you. The plan quotes Trump saying, it goes to you and then you take the money and buy your own
health care. How exactly is that going to work? We'll each get a check every month from the government?
Is the entire insurance system going to be replaced by health savings accounts? Worry not. Trump insists
that prices will come down because he says you'll go out and buy your own health care and you'll make a great deal.
It's quite clear that if someone asked Trump to name two things his plan does, he would not be able to.
This has been one of the defining features of health care policymaking in both Trump terms.
He not only knows almost nothing about the issue, he has no evident beliefs about health care.
In fact, he couldn't care less about it, Waldman said.
Trump does, however, have a simplistic but basic, accurate understanding of what the public wants.
So when speaking off the cuff, he'll say things to make him sound almost liberal.
But when it comes time to produce something that vaguely resembles a policy blueprint,
Trump steps aside and the right-wing ideologues who surround him take over.
In the bulwark, Jonathan Cohen wrote that Trump's great health care plan is not great.
It's not even a plan.
Trump's poll numbers are in the dumps, with voters identifying the high cost of living as a top concern.
That includes the price of health care, which just went up for more than 20 million Americans
who rely on the Affordable Care Act, Cohen said.
Negotiations over enhanced ACA subsidies have since stopped.
making Thursday's plan the latest in a series of chances for Trump to weigh in strongly on what he wants.
And at first blush, it looked like Trump might do just that finally, because he endorsed two key ideas that Republicans have been discussing in the debate over extending the subsidies.
One, which has gotten a fair amount of attention, would take at least some of the money from those extra subsidies and put them instead in tax-favored spending accounts that people could use on health care.
The other idea Trump endorsed is a call to provide funding for something called cost-sharing reductions, Cohen added.
The endorsement of these ideas was conspicuously half-hearted.
It's possible Trump and his advisors were making a conscious, strategic choice
not to slam the door on anything that might come out of the bipartisan talks on Capitol Hill.
But staying out of the process isn't going to get a deal done either,
because getting to 60 votes in the Senate would almost certainly require pressure on Republicans
hesitant to support any extension of the subsidies.
In common dreams, Egan Kemp argued that the plan is doomed to fail.
We need Medicare for all.
President Donald Trump's new great health care plan is anything but, Kemp wrote.
Unsurprisingly, Trump's concepts of a plan failed to even begin to reverse the damage he caused
when he made massive cuts to Medicaid and the Affordable Care Act in order to fund tax cuts for billionaires.
Now, Trump and his Republican allies are trying to cover up the gaping wound they have created with a band-aid.
At the same time, Americans are desperate for relief from Trumplation, including rapidly rising health care costs.
Shut down negotiations and subsequent scattershot health ideas from the White House,
and Republicans in Congress, show that they have no real idea what to do when it comes to
actually bringing down the cost of health care in America. The only alternate Republican plans
for health care that currently exist strictly serve corporations and fail to provide relief to patients,
Kemp said. Fortunately, Medicare for All would address all of these issues and finally put the
health of Americans ahead of corporate profits. Medicare for All would guarantee that everyone in the
U.S. can get great care that they need when they need it, without financial barriers or hoops to jump
through and would be cheaper than our current system while providing coverage that is better than
any commercial health insurance plan. All right, that is it for what the left is saying,
which brings us to what the right is saying. The right sees Trump's health care plan as a mixed
bag. Some say the document falls short of an alternative version to Obamacare. Others endorse
direct payments to Americans over ACA subsidies. In the federalist, Christopher Jacobs described
the good, the bad, and the ugly of the White House health care plan. In theory, sending money to
patients rather than insurance companies will give the American people greater control over their
health care choices while promoting competition, Jacobs wrote. Likewise, proposals to allow more
pharmaceuticals to be sold over-the-counter hold some appeal. Expanding the over-the-counter marketplace
could increase competition while also lowering health care costs by eliminating additional trips to
the doctor to obtain prescriptions. By contrast, Obamacare included language since repealed,
requiring people to obtain a prescription to have over-the-counter medicines reimbursed from a
flexible spending arrangement or health savings account, which resulted in a rush of unnecessary
appointments where patients asked for prescriptions for things like NyQuil. Proposals to increase
transparency, requiring insurers to explain their plans in plain English, publish their rates
of treatment denials, and publicize their percentage of administrative overhead and mandating
providers to publish their prices should help at the margins. The proposal to fund the cost-sharing
reduction program falls into a similarly ambivalent category, Jacob said. The worst of the White House
proposals concerns policies to codify the president's most favored nation deals. American patients
deserve lower health care costs, which several policies in the president's health care plan would
achieve. They don't deserve arbitrary discrimination against the most vulnerable, which could
result from codifying the White House's price control plan. The National Review editors wrote about
Trump's not-so-great health care plan. President Trump deserves credit for thus far resisting
Democrats' demand to throw more money at the failed Obamacare program. But on Tuesday,
he offered a one-page policy response
characteristically titled
The Great American Healthcare Plan
that leaves much to be desired, the editor said.
The outline is mostly small-bore ideas
that range from inadvisable,
importing socialist price controls for pharmaceuticals,
to perfectly fine but inadequate,
allowing more drugs to be purchased over-the-counter
and expanding price transparency.
The plan misses because, ultimately,
it doesn't offer a contrary vision
for health care from Obamacare.
It would be great if Americans had more control
over health care dollars and had the ability to choose for more plans.
But absent broader changes on the regulatory front,
enrollees wouldn't have a real choice,
as they would still be purchasing among Obamacare plans, they added.
To be clear, if the Trump health care outline
serves the purpose of steering antsy Republicans away from a catastrophic decision
to join Democrats in expanding Obamacare,
that alone would be a net positive.
But as an alternative vision for health care,
it isn't big, beautiful, or great.
In reason, J.D. Tochilly said the plan has promise, but should add more freedom for Americans.
The Great Healthcare Plan doesn't really undo the bad government interventions and restrictions that limit choice and raise costs.
The plan might offer some improvement over what we have, but it should be a lot better.
In fact, legislation that would greatly improve the plan has already been presented to Congress, Too Chilli said.
Critics of what we've seen of the Great Healthcare Plan worry that it just builds a little more transparency and a few more options, plus added substance.
subsidies into existing Obamacare distortions of the medical marketplace.
A good place to start in terms of fleshing out the health care plan with details that would
expand choice and patient freedom and lower costs is Senator Rand Paul's Health Marketplace
and Savings Accounts for All Act introduced last month to Chile, wrote.
The bill raises the annual contribution cap on taxed advantage to health savings accounts from
$4,400 for individuals and $8,750 for families to $24,500, and extend, you.
HSA eligibility to everyone.
It also expands what HSAs can cover.
Basically, Paul's bill would dramatically increase Americans' control over their health care money
and make their coverage portable by delinking it from employment.
All right, let's turn over to Will for his take.
Thanks, John.
All right, this is Senior Editor Will Kayback.
Back to read my take.
President Trump's health care plan fell out of the headlines as quickly as it appeared.
And that's understandable.
Greenland, anti-ice protests, and the second phase of the Gaza ceasefire plan are just a few of the major stories that have supplanted it in the past few days.
But the relatively quiet response from lawmakers and commentators to the plan is still surprising to me.
After all, one of the most memorable moments of the 2024 presidential campaign was Trump saying that he had, quote, concepts of a plan for health care,
an assurance that has remained about that vague for roughly a decade.
Now, Trump has finally introduced his proposal, and the reaction seems almost muted.
So what gets?
Well, first off, the great health care plan, which I'll refer to you as just the GHP,
it's a misnomer.
It's really more of a loose framework, the kind of document that works well as a page on a campaign website,
but not as a baseline for actual legislative reform.
While it puts forward some big ideas, Trump's proposal is short on details and shorter on a policy approach.
Several of its prescribed reforms are intriguing to me, but the dearth of fleshed out policies makes it difficult to evaluate,
a reaction that commentators on both sides have seemed to share.
After diving into the responses to Trump's announcement, a few things are clear to me.
One, the GHP is not the Affordable Care Act replacement that Trump has long promised.
It's also unlikely to be adopted wholesale by Republican lawmakers, and finally, it fails to address
many core issues in our health care system. It's more of a gesture toward popular reforms without any
action, an agreeable wish list without a commitment to the trade-offs or political strategy
required to enact anything substantial. Though the GHP is not a cohesive reform agenda,
some of its ideas overlap with real legislative efforts that are worth examining. Most notably,
Trump is pushing to codify his deals on prescription drug prices.
Some Senate Republicans are mobilizing on the call to replace Affordable Care Act subsidies
with direct individual payments.
And Congress's recent bipartisan health care funding agreement includes a crackdown
on pharmacy benefit managers or PBMs.
Now, I have mixed thoughts on each of these proposals, so let's take them one by one.
On drug prices, the GHP leads with a push for most favored nation, also known as MFN deal.
compelling pharmaceutical companies to sell their products at the lowest price that they're sold for in other countries.
Trump signed an executive order last May, directing the Department of Health and Human Services to facilitate these price targets for pharmaceutical companies.
And at the end of 2025, he announced voluntary pricing agreements with nine major manufacturers to bring down drug prices.
However, those same companies recently announced price increases for 872 different names.
name brand medications. And the White House says that the negotiated price reductions are coming to
state Medicaid programs and patients who pay in cash for some prescriptions, not these price increases
that have happened in the past few weeks. But the episode underscores how only legislation,
not executive action, can address drug prices. Relatedly, codifying MFN requirements isn't
guaranteed to bring down prices either, whether through executive order or new legislation.
Americans really do pay much higher drug prices than citizens of other countries, and this policy does
have strong support from the left. But the plan relies on a few risky assumptions, that drug companies
wouldn't pull drugs from the market rather than lower prices or raise prices abroad rather than
lowering them in the U.S. Now I'm less concerned about the risk of stifling innovation, which is a core
concern on the Republican and conservative side. As I've seen recent studies estimate that similar proposals
would have a small impact on the number of new drugs coming to market in the long run.
So in some, codifying MFN pricing, it sounds good in the abstract,
and I could support some proposal,
but Trump's plan offers no details to account for these potential pitfalls in practice.
Now, on the GHP's direct payments to individuals,
these are effectively a replacement for the enhanced ACA subsidies that expired at the end of 2025
and that Democrats are now fighting to reinstate.
Senator Bill Cassidy, a Republican from Louisiana, has offered one of the most detailed proposals for turning this idea into legislation, rerouting funds for the subsidies to individual health savings accounts or HSAs that cover out-of-pocket health care costs.
However, as some Democrats and health policy experts have noted, these savings accounts are only available through plans that carry higher co-pays and deductibles than others.
In effect, this would reduce the savings provided by covering out-of-pocket costs
by forcing people onto the plans with the highest copays and deductibles,
all without addressing the persistent problem of rising premiums,
which HSAs can't be used to pay for.
Perhaps these issues could be addressed with additional reforms,
but again, we haven't seen them.
Cassidy's plan hasn't been written up as a bill,
and Trump's GHP offers no more guidance.
Lastly, pharmacy benefit managers.
PBMs. The bipartisan health care package that legislators passed on Tuesday includes, among other
measures, an overhaul of PBM practices. Today, PBMs decide which drugs are covered by insurance,
meaning that they can earn more when they approve coverage for more expensive drugs, because drug
companies often give bigger discounts on higher-priced medications, and PBMs keep part of that money.
So these new provisions would instead require PBMs be paid a flat fee for their services, and
pass along any discounts they get directly to health insurers instead of keeping those discounts
for themselves. Of all the ideas raised by the GHP with some legislative momentum, PBM reform seems
like the best place to start, removing warped incentives that lead to increase costs across the
health care system. But does the GHP actually help with this effort? Without a clear legislative
strategy from the White House, it's unclear whether Trump wants to save PBM reform for a comprehensive,
to-be-realized health care bill,
or whether he's content with Congress
passing different elements of the proposal
in piecemeal fashion.
Knowing the president, he probably prefers
the former some kind of a bill
that he can label the great health care plan,
but that makes it surprising
that the rollout of this plan
has been so lackluster and really low energy.
I can only speculate,
but my impression is that the administration
lacks the political will at this moment
for a bruising health care fight
while so much of its attention
is focused abroad. And this half-hearted plan signals to Congress that it should take up the reins instead.
Now, that could still change, and I don't think that this story is written or the path it's on right now is
predetermined. But think about it. The midterms are fast approaching, and I think Trump's promise of
comprehensive health care reform seems less and less likely to ever materialize. Another thought stuck
in my head as I was reading commentary from writers on the right and left. All of the analysis I read,
from experts and editorial boards and legislators considering their options,
all of them took health care reforms more seriously than Trump's proposal itself.
And that's deeply disheartening to me.
Just over a year ago, you'll remember that United Healthcare CEO Brian Thompson's killing
laid bare millions of Americans deep-rooted frustrations with our health care system.
And just a few months ago, we had the longest government shutdown in U.S. history,
purportedly on account of needed health care reforms.
Despite lots of talk about action, we still seem to be dancing around the actual decisions of which reforms to prioritize and how to make them law.
Now, Congress at the moment at least seems committed to some measure of reform. But seriously, where is the White House?
Frankly, it's shocking that a president who has been so willing to flex executive power and impose his will on lawmakers when he wants to, has chosen to punt so visibly on such a key issue.
After years of promises, Americans were told that the plan we have now would finally clarify
the president's vision for health care reform. Instead, it underscores just how far we are from a serious,
sustained effort to fix the system nearly everyone agrees is broken. All right, that is it for my take.
I'm going to hand it over to managing editor Ari Weitzman who penned the response to today's reader question.
Ari, over to you. We'll be right back after this quick break.
This is Tangle Managing Editor Ari Weitzman taking today's reader question, which comes from Jake in Grand Rapids, Michigan.
Jake asks, I've seen several reports of DHS displaying supposed Nazi and KKK slogans, one of ours, all of yours, and we'll have our home again.
What do you make of this?
I wanted to be the one to take this question, since I'm the member of Tango staff who most vocally claimed last year that Elon Musk did not make a Nazi salute at Trump's inauguration.
celebration. I still think it's reasonable to disagree over that instance, but a month later,
Steve Bannon unambiguously made a sig hail at CPAC. Seemingly as a troll, and I said that at the time,
quote, this mainstreaming of Nazi salutes, even sarcastically, is an enormous problem for the right,
end quote. To risk egregious understatement, I'd say that problem has gotten worse. Over the past 10 days
alone, official social media accounts for the United States government have posted messages with
clear parallels to Nazi propaganda. On January 10th, the Department of Labor posted a short video on
X with a caption, one homeland, one people, one heritage, in apparent reference to the
Nazi slogan, one people, one empire, one leader. On January 13th, Department of Homeland Security
Secretary Christy Noam stood behind a lectern with a caption, one of ours, all of yours. The slogan
allegedly connected to the
1942 annihilation of
Lydice in the Nazi protectorate
of Bohemia and Moravia.
On January 14th,
the White House posted a cartoon on X
asking which way Greenland Man
referencing a book from 1978
that explicitly argued the inferiority
of Africans and Jews.
All of these apparent references
on their own are explainable.
Three short statements beginning with the word
one are not uncommon.
The slogan DHS used
was actually never used by Nazis and only loosely connected to the Lied Ice Massacre
and which way Western man had already become a flexible meme format long before the White House's
tweet. Then, on January 16th, the Department of Labor, post an on-X will never stop fighting
for the American way of life, America first, Americans first. The first line used the German noun
capitalization and is notably 14 words long, an apparent reference to two prominent neo-Nazi slogans
known as the 14 words. Then the whole post contains spacing that makes it 88 characters in total,
another apparent neo-Nazi reference. Frankly, it strains credulity to dismiss this pattern,
both including the labor tweet and within it, as a string of innocuous coincidences.
These are pretty clearly Nazi dog whistles, signals intended for normal people to miss or dismiss,
but Nazi sympathizers to hear. So why are they doing this?
Maybe employees who manage these accounts have coordinated these messages amongst themselves.
It's a kind of edgy in-group signaling, which Richard Henania has called the base ritual.
Maybe their supervisors don't care.
Or maybe they intend the strategy to both wink at this poisonous portion of their base
while castigating the rest of us who pick up on these subtle, yet troublingly consistent patterns
as hyperventilating pearl clutches.
In my opinion, that's exactly what's happening.
When I asked DHS for comment on these examples, Assistant Secretary Trisha McLaughlin said,
revolting, I already addressed this on CNN and you're actually conspiracy theorists for giving this credibility.
That's it for my answer to this reader question.
I'm going to set it back to John for the rest of the pot.
Thanks, Ari.
Here's your under-the-radar story for today, folks.
China is the world's second most populous nation, but in 2025, its population shrank for the fourth consecutive year.
According to government statistics released Monday, China's total population decreased by 3 million people,
and the birth rate was 5.63 per 1,000 people, the lowest on record since 1949, and a 17% decrease
from the previous year. People in China cite rising costs as a deterrent to having children,
while experts also pointed to the lingering effects of the government's multi-decade one-child policy
that remained in effect until 2015. Though China is viewed as an ascendant world power,
Economists say its population challenges could hamper its long-term growth.
The Associated Press has this story, and there's a link in today's episode description.
And last but not least, our Have a Nice Day story.
The American Cancer Society projects that over 2 million people will be diagnosed with cancer in 2026,
and the disease continues to be a leading cause of death in the U.S.
But new ACS data released on January 13th showed two promising trends,
survival rates for more fatal cancers have improved dramatically over the past few decades,
and for the first time ever, 70% of people diagnosed with cancer live at least five years
after their initial diagnosis. ACS's chief scientific officer, Dr. William DeHut,
identified available treatments, early screenings, and a drop-in tobacco usage as contributors
to the rising survival rates. It's really an exciting point. If we went back to the 1970s,
less than half the people would be cancer-free or surviving at five years, the HUD said.
ABC News has this story and there's a link in today's episode description.
All right, everybody, that is it for today's episode.
As always, if you'd like to support our work, please go to reetangle.com
where you can sign up for a newsletter membership, podcast membership,
or a bundled membership that gets you a discount on both.
We'll be right back here tomorrow.
For Isaac, Will, and the rest of the crew, this is John Law signing off.
Have a great day, y'all.
Peace.
Our executive editor and founder is me.
Isaac Saul and our executive producer is John Law.
Today's episode was edited and engineered by Dewey Thomas.
Our editorial staff is led by managing editor Ari Weitzman with senior editor Will Kback and associate editor, Audrey Moorhead, Lindsay Canuth, and Bailey Saul.
Music for the podcast was produced by Diet 75.
To learn more about Tangle and to sign up for a membership, please visit our website at reetangle.com.
